About
Care and conscience are
the core of our corporate values
more
the core of our corporate values
24 Jul,2025
Zylox-Tonbridge Issues Positive Profit Alert, Expects Over RMB 115 Million in 1H 2025 Net Profit
HANGZHOU, China, July 23, 2025 – Zylox-Tonbridge Medical Technology Co., Ltd. (HKEX: 2190, “Zylox-Tonbridge” or the “Company”), a leading medical device company in China’s peripheral and neurova...
more
28 May,2025
2024 Environmental, Social and Governance Report
more
27 May,2025
ZYLOX Unicorn™ Vascular Closure Device Receives Regulatory Approval in Indonesia
Zylox-Tonbridge Medical Technology Co., Ltd. (“Zylox-Tonbridge” or the “Company”) today announced that its proprietary ZYLOX Unicorn™ Vascular Closure Device (VCD) has received regulatory approva...
more
04 Dec,2024
Zylox-Tonbridge 2024 Investor Open Day Successfully Held in Hangzhou
On November 28, Zylox-Tonbridge ("2190.HK", hereinafter referred to as "the Company") successfully hosted its 2024 Investor Open Day in Hangzhou, China. The event attracted more th...
more
26 Aug,2024
Zylox-Tonbridge Reports Strong Interim Financial Results for 2024, Achieving Significant Growth and Profitability
HANGZHOU, CHINA, August 20, 2024 – Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK), a leading player in China’s peripheral and neurovascular intervention markets, today announced its interim ...
more
22 Mar,2024
Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability
HANGZHOU, CHINA, March 21, 2024 – Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK), a leading medical device company in the peripheral and neurovascular interventional market in China, announc...
more
